Bristol-Myers Squibb Co

General

Total Cases181

Active Cases2

Patents2,995

CourtsD. Delaware D. New Jersey S.D. New York

TypeOperating Company

Elite Ratings

DCT

Ratings

Experience

Grade

Trend

DCT

L4

A

PTAB

L5

A

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
11/01/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	Please be advised that this entry is being made for statistical reporting purposes only re D.E. 192 Text Order. (ams, ) (Entered: 11/01/2024)
10/31/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - The telephone conference set for November 12, 2024 before Magistrate Judge Leda D. Wettre is adjourned to January 23, 2025 at 4:00 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 850 795 61#. So Ordered by Magistrate Judge Leda D. Wettre on 10/31/2024. (rn) (Entered: 10/31/2024) TEXT ORDER - The telephone conference set for November 12, 2024 before Magistrate Judge Leda D. Wettre is adjourned to January 23, 2025 at 4:00 p.m. The parties shall submit concise status letters to the Court no later than one week in advance of the conference. Dial-in information for the conference is (973) 437-5535, access code 850 795 61#. So Ordered by Magistrate Judge Leda D. Wettre on 10/31/2024. (rn) (Entered: 10/31/2024)
10/30/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - This matter is hereby referred to mediation and is administratively terminated pending completion of mediation. The Court shall communicate with the parties as to the selection of the mediator. So Ordered by Judge Claire C. Cecchi on 10/30/2024. (jl, ) (Entered: 10/30/2024)
10/30/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	***Civil Case Terminated. (jl, ) (Entered: 10/30/2024)
10/15/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	Letter from Keith J. Miller, Esq. to Hon. Leda D. Wettre, U.S.M.J. re Case Status Report. (MILLER, KEITH) (Entered: 10/15/2024)
10/01/24	Actelion Pharmaceuticals Ltd v. Bristol Myers Squibb Co 2:21-CV-18695 ( D. NJ )	TEXT ORDER - Per counsel's request (ECF [189] ), the telephone conference set for October 7, 2024 before Magistrate Judge Leda D. Wettre is adjourned to November 12, 2024 at 4:00 p.m. Dial-in information for the conference is (888) 684-8852, access code 8948139. So Ordered by Magistrate Judge Leda D. Wettre on 10/1/2024. (rn) (Entered: 10/01/2024)
09/30/24	Bristol Myers Squibb Co v. Umedica Laboratories Pvt Ltd 1:24-CV-01089 ( D. DE )	Summons Issued as to Umedica Laboratories Pvt. Ltd. on 9/30/2024. (cdd) (Entered: 09/30/2024)
09/30/24	Bristol Myers Squibb Co v. Umedica Laboratories Pvt Ltd 1:24-CV-01089 ( D. DE )	Summons Issued as to Umedica Laboratories Pvt. Ltd. on 9/30/2024. (cdd) (Entered: 09/30/2024)
09/30/24	Bristol Myers Squibb Co v. Umedica Laboratories Pvt Ltd 1:24-CV-01089 ( D. DE )	Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company, Pfizer Inc. (cdd) (Entered: 09/30/2024)
09/30/24	Bristol Myers Squibb Co v. Umedica Laboratories Pvt Ltd 1:24-CV-01089 ( D. DE )	Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company, Pfizer Inc. (cdd) (Entered: 09/30/2024)